Opioid adjuvant strategy: improving opioid effectiveness

Future Medicinal Chemistry
Frédéric Bihel

Abstract

Opioid analgesics continue to be the mainstay of pharmacologic treatment of moderate to severe pain. Many patients, particularly those suffering from chronic pain, require chronic high-dose analgesic therapy. Achieving clinical efficacy and tolerability of such treatment regimens is hampered by the appearance of opioid-induced side effects such as tolerance, hyperalgesia and withdrawal syndrome. Among the therapeutic options to improve the opioid effectiveness, this current review focuses on strategies combining opioids to other drugs that can modulate opioid-mediated effects. We will discuss about experimental evidences reported for several potential opioid adjuvants, including N-methyl-D-aspartate receptor antagonists, 5-HT7 agonists, sigma-1 antagonists, I2-R ligands, cholecystokinin antagonists, neuropeptide FF-R antagonists and toll-like receptor 4 antagonists.

References

Jun 1, 1989·Clinical Pharmacology and Therapeutics·G J LavigneR A Dionne
Nov 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·H Y YangE Costa
May 5, 1995·Neuroscience Letters·C C Chien, G W Pasternak
Nov 30, 1993·European Journal of Pharmacology·C C Chien, G W Pasternak
Jan 1, 1995·Fundamental & Clinical Pharmacology·F Cesselin
Jan 18, 1996·European Journal of Pharmacology·Y KolesnikovG W Pasternak
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·M HannerH Glossmann
Nov 1, 1996·Acta Physiologica Scandinavica·S GrassZ Wiesenfeld-Hallin
May 9, 1997·Brain Research·W YuZ Wiesenfeld-Hallin
May 21, 1998·European Journal of Pharmacology·M Roumy, J M Zajac
Apr 8, 1999·European Journal of Pharmacology·G HorváthG Benedek
Jul 7, 1999·Lancet·H McQuay
Jun 14, 2000·The Journal of Biological Chemistry·N A ElshourbagyH M Sarau
Oct 12, 2000·The Journal of Biological Chemistry·J A BoniniB Borowsky
Mar 15, 2001·Neuroscience Research·P Song, Z Q Zhao
May 30, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·O Yeşilyurt, I T Uzbay
Feb 28, 2002·The Journal of Pharmacology and Experimental Therapeutics·Jianfeng Mei, Gavril W Pasternak
Jun 18, 2002·The Journal of Pharmacology and Experimental Therapeutics·Val J Watts
Jan 25, 2003·Neuroreport·Guy Simonnet, Cyril Rivat
Sep 12, 2003·Journal of Pain and Symptom Management·Rae F BellEija Kalso
Nov 26, 2003·The Journal of Pain : Official Journal of the American Pain Society·Peggy ComptonDavid Elashoff
Mar 19, 2004·Annals of the New York Academy of Sciences·J E PiletzH Zhu
Sep 14, 2004·Journal of Neurobiology·Michael H OssipovFrank Porreca
Nov 16, 2004·European Journal of Pharmacology·Feyza AriciogluSoundar Regunathan
Jan 22, 2005·Current Opinion in Pharmacology·Chris P Bailey, Mark Connor
Mar 2, 2005·European Journal of Pain : EJP·Eija Kalso
Apr 6, 2005·Proceedings of the National Academy of Sciences of the United States of America·Flobert Y TangaJoyce A DeLeo
May 19, 2005·European Journal of Pharmacology·Xiao-Li WeiJin Li
Jun 7, 2005·Current Biology : CB·Li He, Jennifer L Whistler
Aug 3, 2005·Psychopharmacology·Cruz M CendánJosé M Baeyens
Jan 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Frédéric SimoninGuy Simonnet
Mar 15, 2006·Cardiovascular & Hematological Agents in Medicinal Chemistry·G A Head, D N Mayorov
Nov 4, 2006·European Journal of Pharmacology·Francesco GentiliMaria Pigini
Nov 8, 2006·Current Opinion in Pharmacology·Pierre Paoletti, Jacques Neyton
Jan 2, 2007·Pharmacology, Biochemistry, and Behavior·Jennifer M MitchellHoward L Fields
Mar 24, 2007·Neuroscience·F BenedettiL Colloca
Jun 23, 2007·Current Topics in Medicinal Chemistry·S Barret Kalindjian, Iain M McDonald
Sep 28, 2007·Mini Reviews in Medicinal Chemistry·Valeria PittalàGiuseppe Romeo
Oct 12, 2007·CNS Drugs·Angelos Halaris, John Plietz

❮ Previous
Next ❯

Citations

Nov 5, 2016·Current Oncology Reports·Mellar P Davis, Zankhana Mehta
Apr 4, 2017·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Avi A Weinbroum
Jul 25, 2017·ACS Chemical Neuroscience·Thuy NguyenYanan Zhang
Jul 17, 2020·Journal of Medicinal Chemistry·Thuy NguyenYanan Zhang

❮ Previous
Next ❯

Methods Mentioned

BETA
coimmunoprecipitation

Software Mentioned

Rottapharm

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Sultan Qaboos University Medical Journal
Qutaiba Amir TawficRohit R Date
Pain Medicine : the Official Journal of the American Academy of Pain Medicine
Yakov VorobeychikJianren Mao
© 2022 Meta ULC. All rights reserved